Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis
出版年份 2014 全文链接
标题
Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis
作者
关键词
Interventional oncology, Chemoembolization, Embolization, Clinical practice, Liver
出版物
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
Volume 38, Issue 2, Pages 361-371
出版商
Springer Nature
发表日期
2014-11-04
DOI
10.1007/s00270-014-1011-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations
- (2014) Riccardo Lencioni et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy
- (2013) Constantinos T. Sofocleous et al. Clinical Colorectal Cancer
- Safety and Efficacy of Drug-eluting Bead Chemoembolization for Hepatocellular Carcinoma: Comparison of Small-versus Medium-size Particles
- (2013) Siddharth A. Padia et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants
- (2011) Julien Namur et al. JOURNAL OF HEPATOLOGY
- Radiopaque Drug-Eluting Beads for Transcatheter Embolotherapy: Experimental Study of Drug Penetration and Coverage in Swine
- (2011) Matthew R. Dreher et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases
- (2010) Diane Goéré et al. ANNALS OF SURGERY
- Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study
- (2010) Robert C. G. Martin et al. ANNALS OF SURGICAL ONCOLOGY
- Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol
- (2010) Marissa Albert et al. CANCER
- Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry
- (2010) R. C. G. Martin et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy
- (2009) Guy A. van Hazel et al. JOURNAL OF CLINICAL ONCOLOGY
- Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
- (2009) Robert C. G. Martin et al. Journal of Oncology
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Distribution of Iron Oxide–containing Embosphere Particles after Transcatheter Arterial Embolization in an Animal Model of Liver Cancer: Evaluation with MR Imaging and Implication for Therapy
- (2008) Kwang-Hun Lee et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Unresectable Chemorefractory Liver Metastases: Radioembolization with90Y Microspheres—Safety, Efficacy, and Survival
- (2008) Kent T. Sato et al. RADIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started